However, the results of this study give us a reason to conduct some research using more sensitive tools for monitoring anemia and iron status in such patients, like reticulocyte Hb content, percentage of hypochromic RBCs, soluble transferrin receptors, hepcidin, and hypoxia-inducible factor. This evidence concerns the gene HAMP and anemia.